Helicobacter pylori and colorectal neoplasia: Is there a causal link?

World Journal of Gastroenterology

Volumn 22, Issue 2, 2016, Pages 649-658

  Papastergiou, Vasilios ^a   Karatapanis, Stylianos ^a   Georgopoulos, Sotirios D ^b  

^a General Hospital of Rhodes   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

Author keywords

Colorectal cancer; Gastrin; Helicobacter pylori; Polyp; Adenoma

Indexed keywords

GASTRIN;

ATROPHIC GASTRITIS; CASE CONTROL STUDY; CHRONIC GASTRITIS; COLORECTAL ADENOMA; COLORECTAL CANCER; CROSS-SECTIONAL STUDY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; RAPID UREASE TEST; REVIEW; UREA BREATH TEST; CELL TRANSFORMATION; COLORECTAL NEOPLASMS; COMPLICATION; GASTRITIS; GENETICS; HELICOBACTER INFECTIONS; HOST PATHOGEN INTERACTION; MICROBIOLOGY; ONCOGENE; PATHOGENICITY; PRECANCEROUS CONDITIONS; RISK FACTOR;

CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; ONCOGENES; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 84954454192     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i2.649     Document Type: Review

References (94)

1. Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009; 22: 191-197 [PMID: 21037809 DOI: 10.1055/s-0029-1242458]
2. Wilmink AB. Overview of the epidemiology of colorectal cancer. Dis Colon Rectum 1997; 40: 483-493 [PMID: 9106701]
3. Boyle P, Langman JS. ABC of colorectal cancer: Epidemiology. BMJ 2000; 321: 805-808 [PMID: 11009523]
4. Bosman F, Yan P. Molecular pathology of colorectal cancer. Pol J Pathol 2014; 65: 257-266 [PMID: 25693079]
5. Conteduca V, Sansonno D, Russi S, Dammacco F. Precancerous colorectal lesions (Review). Int J Oncol 2013; 43: 973-984 [PMID: 23900573 DOI: 10.3892/ijo.2013.2041]
6. Nagy R, Sweet K, Eng C. Highly penetrant hereditary cancer syndromes. Oncogene 2004; 23: 6445-6470 [PMID: 15322516 DOI: 10.1038/sj.onc.1207714]
7. Le Marchand L, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 1997; 57: 4787-4794 [PMID: 9354440]
8. Lin OS. Acquired risk factors for colorectal cancer. Methods Mol Biol 2009; 472: 361-372 [PMID: 19107442 DOI: 10.1007/978-1-6 0327-492-0-16]
9. Moayyedi P, Hunt RH. Helicobacter pylori public health implications. Helicobacter 2004; 9 Suppl 1: 67-72 [PMID: 15347308 DOI: 10.1111/j.1083-4389.2004.00250.x]
10. Kuipers EJ. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 1997; 11 Suppl 1: 71-88 [PMID: 9146793]
11. Infection with Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 177-240 [PMID: 7715070]
12. Guo Q, Guo S, Zhang Y. Treatment of gastric MALT lymphoma with a focus on Helicobacter pylori eradication. Int J Hematol 2013; 97: 735-742 [PMID: 23616223 DOI: 10.1007/s12185-013-1348-2]
13. Shiotani A, Cen P, Graham DY. Eradication of gastric cancer is now both possible and practical. Semin Cancer Biol 2013; 23: 492-501 [PMID: 23876852 DOI: 10.1016/j.semcancer.2013.07.004]
14. Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, Goebell H. Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion 1999; 60: 210-215 [PMID: 10343134]
15. Fujimori S, Kishida T, Kobayashi T, Sekita Y, Seo T, Nagata K, Tatsuguchi A, Gudis K, Yokoi K, Tanaka N, Yamashita K, Tajiri T, Ohaki Y, Sakamoto C. Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. J Gastroenterol 2005; 40: 887-893 [PMID: 16211345 DOI: 10.1007/s00535-005-1649-1]
16. Hartwich A, Konturek SJ, Pierzchalski P, Zuchowicz M, Labza H, Konturek PC, Karczewska E, Bielanski W, Marlicz K, Starzynska T, Lawniczak M, Hahn EG. Helicobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer. Int J Colorectal Dis 2001; 16: 202-210 [PMID: 11515678]
17. Inoue I, Mukoubayashi C, Yoshimura N, Niwa T, Deguchi H, Watanabe M, Enomoto S, Maekita T, Ueda K, Iguchi M, Yanaoka K, Tamai H, Arii K, Oka M, Fujishiro M, Takeshita T, Iwane M, Mohara O, Ichinose M. Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis: a population-based case-control study. Int J Cancer 2011; 129: 2704-2711 [PMID: 21225622 DOI: 10.1002/ijc.25931]
18. Meucci G, Tatarella M, Vecchi M, Ranzi ML, Biguzzi E, Beccari G, Clerici E, de Franchis R. High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol 1997; 25: 605-607 [PMID: 9451672]
19. Mizuno S, Morita Y, Inui T, Asakawa A, Ueno N, Ando T, Kato H, Uchida M, Yoshikawa T, Inui A. Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer 2005; 117: 1058-1059 [PMID: 15986436 DOI: 10.1002/ijc.21280]
20. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734-1739 [PMID: 1770552]
21. Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A. Helicobacter pylori: seroprevalence and colorectal cancer. Isr Med Assoc J 2000; 2: 6-9 [PMID: 10892362]
22. Georgopoulos SD, Polymeros D, Triantafyllou K, Spiliadi C, Mentis A, Karamanolis DG, Ladas SD. Hypergastrinemia is associated with increased risk of distal colon adenomas. Digestion 2006; 74: 42-46 [PMID: 17068397]
23. Limburg PJ, Stolzenberg-Solomon RZ, Colbert LH, Perez-Perez GI, Blaser MJ, Taylor PR, Virtamo J, Albanes D. Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers. Cancer Epidemiol Biomarkers Prev 2002; 11: 1095-1099 [PMID: 12376513]
24. Machida-Montani A, Sasazuki S, Inoue M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Hanaoka T, Tsugane S. Atrophic gastritis, Helicobacter pylori, and colorectal cancer risk: a case-control study. Helicobacter 2007; 12: 328-332 [PMID: 17669106 DOI: 10.1111/j.1523-5378.2007.00513.x]
25. Moss SF, Neugut AI, Garbowski GC, Wang S, Treat MR, Forde KA. Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst 1995; 87: 762-763 [PMID: 7563155]
26. Penman ID, el-Omar E, Ardill JE, McGregor JR, Galloway DJ, O' Dwyer PJ, McColl KE. Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection. Gastroenterology 1994; 106: 1263-1270 [PMID: 8174887]
27. Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, Koren R, Yahav J. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol 2001; 96: 3406-3410 [PMID: 11774957 DOI: 10.1111/j.1572-0241.2001.05342.x]
28. Siddheshwar RK, Muhammad KB, Gray JC, Kelly SB. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol 2001; 96: 84-88 [PMID: 11197293]
29. Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology 1998; 115: 275-280 [PMID: 9679032]
30. Zhang Y, Hoffmeister M, Weck MN, Chang-Claude J, Brenner H. Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. Am J Epidemiol 2012; 175: 441-450 [PMID: 22294430 DOI: 10.1093/aje/kwr331]
31. Keenan JI, Beaugie CR, Jasmann B, Potter HC, Collett JA, Frizelle FA. Helicobacter species in the human colon. Colorectal Dis 2010; 12: 48-53 [PMID: 20050183]
32. Liou JM, Lin JW, Huang SP, Lin JT, Wu MS. Helicobacter pylori infection is not associated with increased risk of colorectal polyps in Taiwanese. Int J Cancer 2006; 119: 1999-2000 [PMID: 16708392 DOI: 10.1002/ijc.22050]
33. Lin YL, Chiang JK, Lin SM, Tseng CE. Helicobacter pylori infection concomitant with metabolic syndrome further increase risk of colorectal adenomas. World J Gastroenterol 2010; 16: 3841-3846 [PMID: 20698048]
34. Hong SN, Lee SM, Kim JH, Lee TY, Kim JH, Choe WH, Lee S Y, Cheon YK, Sung IK, Park HS, Shim CS. Helicobacter pylori infection increases the risk of colorectal adenomas: cross-sectional study and meta-analysis. Dig Dis Sci 2012; 57: 2184-2194 [PMID: 22669208 DOI: 10.1007/s10620-012-2245-x]
35. Shmuely H, Melzer E, Braverman M, Domniz N, Yahav J. Helicobacter pylori infection is associated with advanced colorectal neoplasia. Scand J Gastroenterol 2014; 49: 35-42 [PMID: 24164483 DOI: 10.3109/00365521.2013.848468]
36. Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis 2000; 181: 1359-1363 [PMID: 10762567]
37. Brim H, Zahaf M, Laiyemo AO, Nouraie M, Pérez-Pérez GI, Smoot DT, Lee E, Razjouyan H, Ashktorab H. Gastric Helicobacter pylori infection associates with an increased risk of colorectal polyps in African Americans. BMC Cancer 2014; 14: 296 [PMID: 24774100 DOI: 10.1186/1471-2407-14-296]
38. Patel S, Lipka S, Shen H, Barnowsky A, Silpe J, Mosdale J, Pan Q, Fridlyand S, Bhavsar A, Abraham A, Viswanathan P, Mustacchia P, Krishnamachari B. The association of H. pylori and colorectal adenoma: does it exist in the US Hispanic population? J Gastrointest Oncol 2014; 5: 463-468 [PMID: 25436126 DOI: 10.3978/j.issn.2078-6891.2014.074]
39. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29 [PMID: 22237781 DOI: 10.3322/caac.20138]
40. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19: 1893-1907 [PMID: 20647400 DOI: 10.1158/1055-9965.EPI-10-0437]
41. Guo Y, Li HY. Association between Helicobacter pylori infection and colorectal neoplasm risk: a meta-analysis based on East Asian population. J Cancer Res Ther 2014; 10 Suppl: 263-266 [PMID: 25693932 DOI: 10.4103/0973-1482.151482]
42. Rokkas T, Sechopoulos P, Pistiolas D, Kothonas F, Margantinis G, Koukoulis G. The relationship of Helicobacter pylori infection and colon neoplasia, on the basis of meta-analysis. Eur J Gastroenterol Hepatol 2013; 25: 1286-1294 [PMID: 23820245 DOI: 10.1097/MEG.0b013e328363d3cd]
43. Wu Q, Yang ZP, Xu P, Gao LC, Fan DM. Association between Helicobacter pylori infection and the risk of colorectal neoplasia: a systematic review and meta-analysis. Colorectal Dis 2013; 15: e352-e364 [PMID: 23672575 DOI: 10.1111/codi.12284]
44. Zhao YS, Wang F, Chang D, Han B, You DY. Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer. Int J Colorectal Dis 2008; 23: 875-882 [PMID: 18506454 DOI: 10.1007/s00384-008-0479-z]
45. Zumkeller N, Brenner H, Zwahlen M, Rothenbacher D. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter 2006; 11: 75-80 [PMID: 16579836 DOI: 10.1111/j.1523-5378.2006.00381.x]
46. Chen YS, Xu SX, Ding YB, Huang XE, Deng B. Helicobacter pylori Infection and the risk of colorectal adenoma and adeno-carcinoma: an updated meta-analysis of different testing methods. Asian Pac J Cancer Prev 2013; 14: 7613-7619 [PMID: 24460342]
47. Sonnenberg A, Genta RM. Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol 2013; 108: 208-215 [PMID: 23208272 DOI: 10.1038/ajg.2012.407]
48. Plummer M. Helicobacter pylori and colonic neoplasms. Am J Gastroenterol 2013; 108: 216-217 [PMID: 23381070 DOI: 10.1038/ajg.2012.409]
49. Laiyemo AO, Kamangar F, Marcus PM, Taylor PR, Virtamo J, Albanes D, Stolzenberg-Solomon RZ. Atrophic gastritis and the risk of incident colorectal cancer. Cancer Causes Control 2010; 21: 163-170 [PMID: 19838812 DOI: 10.1007/s10552-009-9446-4]
50. Lahner E, Sbrozzi-Vanni A, Vannella L, Corleto VD, Di Giulio E, Delle Fave G, Annibale B. No higher risk for colorectal cancer in atrophic gastritis-related hypergastrinemia. Dig Liver Dis 2012; 44: 793-797 [PMID: 22595617 DOI: 10.1016/j.dld.2012.04.012]
51. Inoue I, Kato J, Yoshimura N, Maeda Y, Moribata K, Shingaki N, Deguchi H, Enomoto S, Maekita T, Ueda K, Iguchi M, Tamai H, Fujishiro M, Yamamichi N, Takeshita T, Ichinose M. Elevated risk of recurrent colorectal neoplasia with Helicobacter pylori-associated chronic atrophic gastritis: A follow-up study of patients with endoscopically resected colorectal neoplasia. Mol Clin Oncol 2013; 1: 75-82 [PMID: 24649126 DOI: 10.3892/mco.2012.22]
52. Konturek SJ, Konturek PC, Hartwich A, Hahn EG. Helicobacter pylori infection and gastrin and cyclooxygenase expression in gastric and colorectal malignancies. Regul Pept 2000; 93: 13-19 [PMID: 11033048]
53. Sobhani I, Lehy T, Laurent-Puig P, Cadiot G, Ruszniewski P, Mignon M. Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa. Gastroenterology 1993; 105: 22-30 [PMID: 8514038]
54. Houli N, Loh SW, Giraud AS, Baldwin GS, Shulkes A. Mitogenic effects of both amidated and glycine-extended gastrin-releasing peptide in defunctioned and azoxymethane-treated rat colon in vivo. Regul Pept 2006; 134: 9-16 [PMID: 16297463]
55. Malecka-Panas E, Fligiel SE, Jaszewski R, Majumdar AP. Differential responsiveness of proximal and distal colonic mucosa to gastrin. Peptides 1997; 18: 559-565 [PMID: 9210176]
56. Lee S, Hwang KS, Lee HJ, Kim JS, Kang GH. Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest 2004; 84: 884-893 [PMID: 15122305 DOI: 10.1038/labinvest.370010]
57. Hawkins N, Norrie M, Cheong K, Mokany E, Ku SL, Meagher A, O'Connor T, Ward R. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 2002; 122: 1376-1387 [PMID: 11984524]
58. Soylu A, Ozkara S, Alis H, Dolay K, Kalayci M, Yasar N, Kumbasar AB. Immunohistochemical testing for Helicobacter Pylori existence in neoplasms of the colon. BMC Gastroenterol 2008; 8: 35 [PMID: 18702825 DOI: 10.1186/1471-230X-8-35]
59. Jones M, Helliwell P, Pritchard C, Tharakan J, Mathew J. Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship? World J Surg Oncol 2007; 5: 51 [PMID: 17498313]
60. Renga M, Brandi G, Paganelli GM, Calabrese C, Papa S, Tosti A, Tomassetti P, Miglioli M, Biasco G. Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia. Gut 1997; 41: 330-332 [PMID: 9378387]
61. Sirinek KR, Levine BA, Moyer MP. Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells. Am J Surg 1985; 149: 35-39 [PMID: 3966639]
62. Watson SA, Durrant LG, Morris DL. Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitro. Br J Surg 1988; 75: 342-345 [PMID: 3359147]
63. Wang TC, Koh TJ, Varro A, Cahill RJ, Dangler CA, Fox JG, Dockray GJ. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest 1996; 98: 1918-1929 [PMID: 8878444 DOI: 10.1172/JCI118993]
64. Koh TJ, Goldenring JR, Ito S, Mashimo H, Kopin AS, Varro A, Dockray GJ, Wang TC. Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice. Gastroenterology 1997; 113: 1015-1025 [PMID: 9287997]
65. Koh TJ, Dockray GJ, Varro A, Cahill RJ, Dangler CA, Fox JG, Wang TC. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. J Clin Invest 1999; 103: 1119-1126 [PMID: 10207163 DOI: 10.1172/JCI4910]
66. Kikendall JW, Glass AR, Sobin LH, Bowen PE. Serum gastrin is not higher in subjects with colonic neoplasia. Am J Gastroenterol 1992; 87: 1394-1397 [PMID: 1415093]
67. Selgrad M, Bornschein J, Kandulski A, Hille C, Weigt J, Roessner A, Wex T, Malfertheiner P. Helicobacter pylori but not gastrin is associated with the development of colonic neoplasms. Int J Cancer 2014; 135: 1127-1131 [PMID: 24496701 DOI: 10.1002/ijc.28758]
68. Singh M, Dhindsa G, Friedland S, Triadafilopoulos G. Long-term use of proton pump inhibitors does not affect the frequency, growth, or histologic characteristics of colon adenomas. Aliment Pharmacol Ther 2007; 26: 1051-1061 [PMID: 17877512]
69. Orbuch M, Venzon DJ, Lubensky IA, Weber HC, Gibril F, Jensen RT. Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome. Dig Dis Sci 1996; 41: 604-613 [PMID: 8617144]
70. Baldwin GS, Zhang QX. Measurement of gastrin and transforming growth factor alpha messenger RNA levels in colonic carcinoma cell lines by quantitative polymerase chain reaction. Cancer Res 1992; 52: 2261-2267 [PMID: 1559230]
71. Finley GG, Koski RA, Melhem MF, Pipas JM, Meisler AI. Expression of the gastrin gene in the normal human colon and colorectal adenocarcinoma. Cancer Res 1993; 53: 2919-2926 [PMID: 8504433]
72. Singh P, Dai B, Wu H, Owlia A. Role of autocrine and endocrine gastrin-like peptides in colonic carcinogenesis. Curr Opin Gastroenterol 2000; 16: 68-77 [PMID: 17024020]
73. Bombski G, Gasiorowska A, Orszulak-Michalak D, Neneman B, Kotynia J, Strzelczyk J, Janiak A, Malecka-Panas E. Elevated plasma gastrin, CEA, and CA 19-9 levels decrease after colorectal cancer resection. Int J Colorectal Dis 2003; 18: 148-152 [PMID: 12548418 DOI: 10.1007/s00384-002-0420-9]
74. Charnley RM, Thomas WM, Stanley J, Morris DL. Serum gastrin concentrations in colorectal cancer patients. Ann R Coll Surg Engl 1992; 74: 138-140; discussion 141 [PMID: 1567134]
75. Kanno T, Matsuki T, Oka M, Utsunomiya H, Inada K, Magari H, Inoue I, Maekita T, Ueda K, Enomoto S, Iguchi M, Yanaoka K, Tamai H, Akimoto S, Nomoto K, Tanaka R, Ichinose M. Gastric acid reduction leads to an alteration in lower intestinal microfora. Biochem Biophys Res Commun 2009; 381: 666-670 [PMID: 19248769 DOI: 10.1016/j.bbrc.2009.02.109]
76. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 2005; 51 Suppl 1: 1-22 [PMID: 15855746]
77. Wu S, Morin PJ, Maouyo D, Sears CL. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 2003; 124: 392-400 [PMID: 12557145 DOI: 10.1053/gast.2003.50047]
78. Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, Celenk T, Soyletir G. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect 2006; 12: 782-786 [PMID: 16842574]
79. Wang X, Allen TD, May RJ, Lightfoot S, Houchen CW, Huycke MM. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res 2008; 68: 9909-9917 [PMID: 19047172 DOI: 10.1158/0008-5472. CAN-08-1551]
80. Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J, Furet JP. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011; 6: e16393 [PMID: 21297998 DOI: 10.1371/journal.pone.0016393]
81. Stemmermann GN, Nomura AM, Chyou PH. Cancer incidence following subtotal gastrectomy. Gastroenterology 1991; 101: 711-715 [PMID: 1860635]
82. Bundred NJ, Whitfield BC, Stanton E, Prescott RJ, Davies GC, Kingsnorth AN. Gastric surgery and the risk of subsequent colorectal cancer. Br J Surg 1985; 72: 618-619 [PMID: 4027533]
83. Toftgaard C. Risk of colorectal cancer after surgery for benign peptic ulceration. Br J Surg 1987; 74: 573-575 [PMID: 3620860]
84. Lundegårdh G, Adami HO, Helmick C, Zack M. The risk of large bowel cancer after partial gastrectomy for benign ulcer disease. Ann Surg 1990; 212: 714-719 [PMID: 2256763]
85. Parsonnet J, Shmuely H, Haggerty T. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA 1999; 282: 2240-2245 [PMID: 10605976]
86. Kapetanakis N, Kountouras J, Zavos C, Polyzos SA, Kouklakis G, Venizelos I, Nikolaidou C, Vardaka E, Paikos D, Katsinelos P, Romiopoulos I. Helicobacter pylori infection and colorectal carcinoma: pathologic aspects. J Gastrointest Oncol 2012; 3: 377-379 [PMID: 23205317 DOI: 10.3978/j.issn.2078-6891.2012.041]
87. Grahn N, Hmani-Aifa M, Fransén K, Söderkvist P, Monstein HJ. Molecular identification of Helicobacter DNA present in human colorectal adenocarcinomas by 16S rDNA PCR amplifcation and pyrosequencing analysis. J Med Microbiol 2005; 54: 1031-1035 [PMID: 16192433 DOI: 10.1099/jmm.0.46122-0]
88. Bulajic M, Stimec B, Ille T, Jesenofsky R, Kecmanovic D, Pavlov M, Ceranic M, Schneider-Brachert W, Lowenfels A, Maisonneuve P, Löhr J. PCR detection of helicobacter pylori genome in colonic mucosa: normal and malignant. Prilozi 2007; 28: 25-38 [PMID: 18356777]
89. Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 2000; 12: 78-85 [PMID: 10623446 DOI: 10.1006/cyto.1999.0518]
90. Konturek PC, Konturek SJ, Bielanski W, Karczewska E, Pierzchalski P, Duda A, Starzynska T, Marlicz K, Popiela T, Hartwich A, Hahn EG. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans. J Physiol Pharmacol 1999; 50: 857-873 [PMID: 10695565]
91. Kuipers EJ, Pérez-Pérez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995; 87: 1777-1780 [PMID: 7473834]
92. Stroflas A, Lagoudianakis EE, Seretis C, Pappas A, Koronakis N, Keramidaris D, Koukoutsis I, Chrysikos I, Manouras I, Manouras A. Association of helicobacter pylori infection and colon cancer. J Clin Med Res 2012; 4: 172-176 [PMID: 22719803 DOI: 10.4021/jocmr880w]
93. Amedei A, Munari F, Bella CD, Niccolai E, Benagiano M, Bencini L, Cianchi F, Farsi M, Emmi G, Zanotti G, de Bernard M, Kundu M, D'Elios MM. Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma. Intern Emerg Med 2014; 9: 303-309 [PMID: 23054412 DOI: 10.1007/s11739-012-0867-9]
94. Zhao Y, Feng F, Zhou YN. Stem cells in gastric cancer. World J Gastroenterol 2015; 21: 112-123 [PMID: 25574084 DOI: 10.3748/wjg.v21.i1.112]